文献速递肿瘤 PET/CT

长轴视野68Ga-PSMA-11 PET在前列腺癌中优于短轴视野PET的头对头比较

Superiority of long axial field-of-view 68Ga-PSMA-11 PET over short axial field-of-view PET in prostate cancer: a head-to-head comparison.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2025-09-27

34例前列腺癌患者同日接受长轴视野(LAFOV)与短轴视野(SAFOV)68Ga-PSMA-11 PET/CT双扫描。LAFOV PET图像质量主观与客观参数均更优,病灶SUVmax、SNR、TBR更高;17.65%患者LAFOV检出SAFOV未识别的额外病灶,其中生化复发患者33.33%、新诊断患者9.09%,并导致临床管理显著改变。

要点

  • LAFOV 68Ga-PSMA-11 PET图像质量主观评分及客观参数均优于SAFOV PET。
  • LAFOV较SAFOV在17.65%患者中检出额外病灶,生化复发者33.33%、新诊断者9.09%。
  • LAFOV检出的额外病灶导致临床管理发生显著改变。

核心结论

  • 头对头比较中,LAFOV 68Ga-PSMA-11 PET较SAFOV PET图像质量更优、病灶检出增强,并对生化复发和新诊断前列腺癌患者的临床管理产生显著影响。
  • 作者认为LAFOV 68Ga-PSMA-11 PET可能成为前列腺癌全面评估的首选影像方法。

研究设计与样本

  • 共纳入34例接受常规68Ga-PSMA-11 PET/CT的前列腺癌患者,采用同日双扫描方案。
  • 一半患者先接受临床常规SAFOV PET(连续床旁运动),随后立即行LAFOV PET(list mode采集5分钟);另一半患者扫描顺序相反。
  • 比较LAFOV与SAFOV 68Ga-PSMA-11 PET的图像质量,采用主观评分与客观参数(SUVmax、SUVmean、SNR、TBR)。

主要发现

  • 基于主观与客观参数,LAFOV 68Ga-PSMA-11 PET图像质量优于SAFOV PET。
  • LAFOV 68Ga-PSMA-11 PET较SAFOV PET图像质量更好,病灶SUVmax、SNR、TBR更高。
  • 17.65%的患者中,LAFOV 68Ga-PSMA-11 PET检出SAFOV未识别的额外病灶。
  • LAFOV较SAFOV在33.33%的生化复发患者和9.09%的新诊断前列腺癌患者中检出额外病灶,导致临床管理显著改变。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Previous studies have shown that long axial field-of-view (LAFOV) 68Ga-PSMA-11 PET/CT can significantly improve the detection rate compared to short axial field-of-view (SAFOV) 68Ga-PSMA-11 PET/CT in prostate cancer. However, the diagnostic efficiency between the two scans was compared in different cohorts, not directly within the same patients. Whether LAFOV 68Ga-PSMA-11 PET could improve image quality, enhance lesion quantification, and impact patient treatment decisions in the same patients remains unclear. To address this research gap, we performed a direct comparison of LAFOV and SAFOV 68Ga-PSMA-11 PET in the same cohort of prostate cancer patients to evaluate whether LAFOV 68Ga-PSMA-11 PET could enhance lesion identification and modify clinical management compared to SAFOV 68Ga-PSMA-11 PET. METHODS: Thirty-four patients with prostate cancer undergoing routine 68Ga-PSMA-11 PET/CT were included and underwent a same-day dual-scanning protocol. Half of the patients first underwent a clinically routine SAFOV PET scan using continuous bed motion, followed immediately by LAFOV PET (5-minute acquisition in list mode); the other half underwent scanning in the reverse order. The image quality of LAFOV and SAFOV 68Ga-PSMA-11 PET was compared using subjective scoring and objective parameters. Objective parameters, including maximum and mean standardized uptake values (SUVmax and SUVmean), signal-to-noise ratio (SNR), and tumor-to-background ratio (TBR), were measured and compared. RESULTS: LAFOV 68Ga-PSMA-11 PET exhibited superior image quality compared to SAFOV PET based on both subjective and objective parameters. LAFOV 68Ga-PSMA-11 PET had better image quality and higher lesion SUVmax, SNR, and TBR compared to SAFOV PET. In 17.65% of patients, LAFOV 68Ga-PSMA-11 PET detected additional lesions that were unidentified on SAFOV 68Ga-PSMA-11 PET. Compared to SAFOV 68Ga-PSMA-11 PET, LAFOV 68Ga-PSMA-11 PET detected additional lesions in 33.33% of patients with biochemical recurrence and 9.09% of patients with newly diagnosed prostate cancer, leading to significant changes in clinical management. CONCLUSIONS: In this head-to-head comparison, LAFOV 68Ga-PSMA-11 PET demonstrated superior image quality, enhanced lesion detection, and a significant impact on clinical management for both biochemical recurrence and newly diagnosed prostate cancer patients compared to SAFOV 68Ga-PSMA-11 PET. These findings suggest that LAFOV 68Ga-PSMA-11 PET may be the preferred imaging modality for comprehensive prostate cancer evaluation.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Wang Y, Zhu L, Xu L, et al. Superiority of long axial field-of-view 68Ga-PSMA-11 PET over short axial field-of-view PET in prostate cancer: a head-to-head comparison. Eur J Nucl Med Mol Imaging. 2025. PMID: 41014335. doi:10.1007/s00259-025-07546-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。